CWM
JAZZ icon

Calamos Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Calamos Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-34,665
Closed -$4.3M – 333
2023
Q2 		$4.3M Sell
34,665
-590
-2% -$79.4K 0.32% 71
2023
Q1 		$5.16M Sell
35,255
-12,616
-26% -$1.87M 0.4% 68
2022
Q4 		$7.63M Sell
47,871
-492
-1% -$72.1K 0.59% 47
2022
Q3 		$6.45M Buy
48,363
+1,626
+3% +$247K 0.55% 47
2022
Q2 		$7.29M Buy
46,737
+1,898
+4% +$292K 0.65% 42
2022
Q1 		$6.98M Buy
44,839
+16,437
+58% +$2.39M 0.52% 47
2021
Q4 		$3.62M Sell
28,402
-601
-2% -$79K 0.26% 85
2021
Q3 		$3.78M Buy
+29,003
New +$4.38M 0.31% 77
2016
Q2 		– Sell
-2,522
Closed -$329K – 252
2016
Q1 		$329K Sell
2,522
-631
-20% -$78.5K 0.06% 208
2015
Q4 		$443K Sell
3,153
-334
-10% -$46.3K 0.09% 200
2015
Q3 		$463K Buy
3,487
+13
+0.4% +$2.24K 0.11% 185
2015
Q2 		$612K Buy
+3,474
New +$624K 0.14% 176
2014
Q4 		– Sell
-4,649
Closed -$746K – 219
2014
Q3 		$746K Sell
4,649
-5,040
-52% -$775K 0.22% 151
2014
Q2 		$1.42M Sell
9,689
-98
-1% -$13.6K 0.41% 95
2014
Q1 		$1.36M Buy
9,787
+885
+10% +$133K 0.4% 101
2013
Q4 		$1.13M Sell
8,902
-2,907
-25% -$301K 0.35% 102
2013
Q3 		$1.09M Buy
11,809
+330
+3% +$26.6K 0.35% 98
2013
Q2 		$789K Buy
+11,479
New +$702K 0.28% 111

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Calamos Wealth Management's JAZZ Position: Q3 2023 in Review

Calamos Wealth Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2023, closing a stake of 34,665 shares — an estimated $4.3M sold.

Calamos Wealth Management first reported a position in JAZZ in Q2 2013 and held it in 18 quarters. The position peaked at $7.63M in Q4 2022. 484 funds tracked by Wall St. Rank hold JAZZ as of Q3 2023.

  • Calamos Wealth Management reported no remaining Jazz Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Calamos Wealth Management sold 34,665 Jazz Pharmaceuticals shares in Q3 2023, an estimated $4.3M.
  • Calamos Wealth Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Calamos Wealth Management's Jazz Pharmaceuticals position peaked at $7.63M in Q4 2022.
  • 484 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2023.

Based on Calamos Wealth Management's 13F filing for Q3 2023, filed 26 Oct 2023.